Table 3.
Incremental Cost-Effectiveness Ratio Every 3 Years and 5 Years
| Modality | ICER Per QALY (3 years) |
ICER Per QALY (5 years) |
|---|---|---|
| HPV vs Pap smear | USD 26,106.18 | USD 15,473.22 |
| VIA vs NS | USD 438.27 | USD 382.65 |
| Pap smear vs NS | USD 874.71 | USD 672.02 |
| HPV vs NS | USD 3,365.95 | USD 2,568.53 |
| Pap vs VIA | USD 3,781.65 | USD 2,156.21 |
| HPV vs VIA | USD 13,968.24 | USD 8,467.05 |